Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00731731 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

125

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma

Interventions

RADIATION: 3-Dimensional Conformal Radiation Therapy
PROCEDURE: Cognitive Assessment
OTHER: Laboratory Biomarker Analysis
DRUG: Temozolomide
DRUG: Vorinostat

Sponsor

National Cancer Institute (NCI)